• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM; BIORESORBABLE DRUG ELUTING SCAFFOLD Back to Search Results
Catalog Number 1012463-28
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Hypersensitivity/Allergic reaction (1907); Stenosis (2263)
Event Date 09/01/2016
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Date of event - estimate.The absorb device is currently not commercially available in the u.S; however, it is similar to a device sold in the us.There was no reported device malfunction and the product was not returned as the scaffold remains in the anatomy.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of angina, hypersensitivity and restenosis, as listed in the bioresorbable vascular scaffold (bvs) system, absorb, instructions for use are known adverse events associated with the use of a coronary scaffold in native coronary arteries.Based on the case information and related record review, a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined and the treatment appears to be related to the circumstances of the procedure.There is no indication of a product quality issue with respect to design, manufacture or labeling of the device.
 
Event Description
It was reported that the procedure on (b)(6) 2016 was to treat a 90% stenosis in the left anterior descending artery.Pre-dilatation was done with a 2.0 x 12 mm non-compliant (nc) balloon reducing the stenosis to less than 40%.A 3.0 x 28 mm absorb scaffold was implanted and post-dilated with a 3.0 x 12 mm nc balloon at 18 atm with final residual stenosis less than 10%.The patient began experiencing chest pain in (b)(6) 2016.Angiography was done on (b)(6) 2016 and 95% restenosis was confirmed in the scaffold as well as a 90% stenosis in the right coronary artery.Re-intervention was done on (b)(6) 2016 at which time non-abbott stents were implanted in both vessels for treatment with a good result.It was confirmed that the patient had been compliant with dual antiplatelet therapy after the procedure.The patient further reported that he had developed allergies after implantation of the absorb scaffold which required treatment; however, the physician had no knowledge of this.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ABSORB BIORESORBABLE VASCULAR SCAFFOLD SYSTEM
Type of Device
BIORESORBABLE DRUG ELUTING SCAFFOLD
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key6289888
MDR Text Key66162294
Report Number2024168-2017-00801
Device Sequence Number1
Product Code PNY
UDI-Device Identifier08717648157042
UDI-Public(01)08717648157042(17)160816(10)508186A
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P150023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Patient
Remedial Action Other
Type of Report Initial
Report Date 01/31/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/31/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/16/2016
Device Catalogue Number1012463-28
Device Lot Number508186A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/10/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
-
-